Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

Uncover Disease Genes by Maximizing Information Flow in the Phenome-Interactome Network.

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

Constructing Human Phenome-Interactome Networks for the Prioritization of Candidate Genes

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

Walking on Multiple Disease-Gene Networks to Prioritize Candidate Genes.

Integrating Multiple Protein-Protein Interaction Networks to Prioritize Disease Genes: a Bayesian Regression Approach

A protein-phenotype mutual information based identification of human disease genes

Network-Based Global Inference of Human Disease Genes

Integrating Phenotypic Features and Tissue-Specific Information to Prioritize Disease Genes

A network-based machine-learning framework to identify both functional modules and disease genes

A Computational Method Based On The Integration Of Heterogeneous Networks For Predicting Disease-Gene Associations

Prioritizing Protein Complexes Implicated in Human Diseases by Network Optimization.

Prioritization of Potential Candidate Disease Genes by Topological Similarity of Protein-Protein Interaction Network and Phenotype Data.

Pinpointing Disease Genes Through Phenomic and Genomic Data Fusion

Phen2Disease: a phenotype-driven model for disease and gene prioritization by bidirectional maximum matching semantic similarities.

Prioritization of Candidate Disease Genes by Enlarging the Seed Set and Fusing Information of the Network Topology and Gene Expression

Align Human Interactome with Phenome to Identify Causative Genes and Networks Underlying Disease Families.

Prioritization of candidate disease genes by combining topological similarity and semantic similarity

A New Method for Disease-Related Gene Prioritization

A Comprehensive Evaluation of Disease Phenotype Networks for Gene Prioritization